Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet's disease

Human Immunology

Volumn 74, Issue 2, 2013, Pages 230-233

  Cénit, María Carmen ^a   Ortego Centeno, Norberto ^b   Raya, Enrique ^b   Callejas, José L ^b   García Hernandez, Francisco J ^c   Castillo Palma, María Jesús ^c   Fernandez Sueiro, J L ^d   Magro, Cesar ^b   Solans, Roser ^e   Castañeda, Santos ^f   Camps, Maite ^g   Hidalgo, Ana ^h   Espinosa, Gerard ⁱ   González Gay, Miguel A ^j   Gonzalez Escribano M F ^c   Martín, Javier ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d Hospital Canalejo   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^g HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

ⁱ HOSPITAL CLÍNIC   (Spain)

^j HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

STAT3 PROTEIN;

ARTICLE; BEHCET DISEASE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ARTHRITIS, PSORIATIC; BEHCET SYNDROME; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; STAT3 TRANSCRIPTION FACTOR;

EID: 84872597492     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.10.019     Document Type: Article

References (27)

1. de Menthon M., Lavalley M.P., Maldini C., Guillevin L., Mahr A. HLA-B51/B5 and the risk of Behcet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum. 2009, 61(10):1287-1296.
2. *06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. Ann. Rheum. Dis. 2008, 67(5):677-682.
3. Ellinghaus E., Stuart P.E., Ellinghaus D., Nair R.P., Debrus S., Raelson J.V., et al. Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL. J. Invest. Dermatol. 2012, 132(4):1133-1140.
4. Huffmeier U., Uebe S., Ekici A.B., Bowes J., Giardina E., Korendowych E., et al. Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat. Genet. 2010, 42(11):996-999.
5. Mizuki N., Meguro A., Ota M., Ohno S., Shiota T., Kawagoe T., et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet's disease susceptibility loci. Nat. Genet. 2010, 42(8):703-706.
6. Remmers E.F., Cosan F., Kirino Y., Ombrello M.J., Abaci N., Satorius C., et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nat. Genet. 2010, 42(8):698-702.
7. Cho J.H., Gregersen P.K. Genomics and the multifactorial nature of human autoimmune disease. N. Engl. J. Med. 2011, 365(17):1612-1623.
8. O'Rielly D.D., Rahman P. Genetics of susceptibility and treatment response in psoriatic arthritis. Nat. Rev. Rheumatol. 2011, 7(12):718-732.
9. Reveille J.D. The genetic basis of spondyloarthritis. Ann. Rheum. Dis. 2011, 70(Suppl 1):i44-i50.
10. Pineton de Chambrun M., Wechsler B., Geri G., Cacoub P., Saadoun D. New insights into the pathogenesis of Behcet's disease. Autoimmun. Rev. 2012, 11(10):687-698.
11. Adamson A.S., Collins K., Laurence A., O'Shea J.J. The current STATus of lymphocyte signaling: new roles for old players. Curr. Opin. Immunol. 2009, 21(2):161-166.
12. Harris T.J., Grosso J.F., Yen H.R., Xin H., Kortylewski M., Albesiano E., et al. Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J. Immunol. 2007, 179(7):4313-4317.
13. Jandus C., Bioley G., Rivals J.P., Dudler J., Speiser D., Romero P. Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis. Rheum. 2008, 58(8):2307-2317.
14. Gonzalez-Navajas J.M., Lee J., David M., Raz E. Immunomodulatory functions of type I interferons. Nat. Rev. Immunol. 2012, 12(2):125-135.
15. Niemand C., Nimmesgern A., Haan S., Fischer P., Schaper F., Rossaint R., et al. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3. J. Immunol. 2003, 170(6):3263-3272.
16. Barrett J.C., Hansoul S., Nicolae D.L., Cho J.H., Duerr R.H., Rioux J.D., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 2008, 40(8):955-962.
17. Sawcer S., Hellenthal G., Pirinen M., Spencer C.C., Patsopoulos N.A., Moutsianas L., et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476(7359):214-219.
18. Cenit M.C., Alcina A., Marquez A., Mendoza J.L., Diaz-Rubio M., De las Heras V., et al. STAT3 locus in inflammatory bowel disease and multiple sclerosis susceptibility. Genes Immun. 2010, 11(3):264-268.
19. Danoy P., Pryce K., Hadler J., Bradbury L.A., Farrar C., Pointon J., et al. Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease. PLoS Genet. 2010, 6(12):e1001195.
20. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet 1990;335(8697):1078-80.
21. Taylor W., Gladman D., Helliwell P., Marchesoni A., Mease P., Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006, 54(8):2665-2673.
22. Ho P., Bruce I.N., Silman A., Symmons D., Newman B., Young H., et al. Evidence for common genetic control in pathways of inflammation for Crohn's disease and psoriatic arthritis. Arthritis Rheum. 2005, 52(11):3596-3602.
23. Lees C.W., Barrett J.C., Parkes M., Satsangi J. New IBD genetics: common pathways with other diseases. Gut 2011, 60(12):1739-1753.
24. Batliwalla F.M., Li W., Ritchlin C.T., Xiao X., Brenner M., Laragione T., et al. Microarray analyses of peripheral blood cells identifies unique gene expression signature in psoriatic arthritis. Mol. Med. 2005, 11(1-12):21-29.
25. Zhou Z.Y., Chen S.L., Shen N., Lu Y. Cytokines and Behcet's disease. Autoimmun. Rev. 2012, 11(10):699-704.
26. Elkayam O., Yaron I., Shirazi I., Yaron M., Caspi D. Serum levels of IL-10, IL-6, IL-1ra, and sIL-2R in patients with psoriatic arthritis. Rheumatol. Int. 2000, 19(3):101-105.
27. Hu K., Hou S., Jiang Z., Kijlstra A., Yang P. JAK2 and STAT3 polymorphisms in a Han Chinese population with Behcet's disease. Invest. Ophthalmol. Vis. Sci. 2012, 53(1):538-541.